 |
 |
|
|
|
|
 |
ȸ»ç¼Ò°³
Driven by the powerful R&D capability with a force of over 300 international scientists and an global extensive network, Venturepharm has over 400 non-patent infringed products approved, pending or under development and 6 NCEs before clinical stages as well as over 200 APIs and key intermediates. Venturepharm has established 8 R&D centers, 3 GMP integrated manufacture facilities and 4 bulk API manufacturing facilities, two of them are approved & USFDA inspected.
|
 |
|
|
 |
ÇöÈÇо÷ü°¡ Á¦Á¶ÇÏ´Â ÈÇÐÁ¦Ç° ¸ñ·Ï |
 |
 |
ÇöÈÇо÷ü°¡ Á¦Á¶ ¶Ç´Â ÆÇ¸ÅÇÏ´Â ÈÇй°Áú ¸ñ·Ï |
 |
ÇöÈÇо÷ü·Î µî·ÏµÈ ÈÇй°ÁúÀÌ ¾ø½À´Ï´Ù! |
|
|